Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

687
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
687
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

2.0K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

619
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
619
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.4K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.4K
Assessment of Respiration01:23

Assessment of Respiration

2.2K
The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
2.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma heparan sulfate structural variation and phenotypic heterogeneity in pediatric Acute Respiratory Distress Syndrome.

Scientific reports·2026
Same author

Plasma Heparan Sulfate Structural Variation and Phenotypic Heterogeneity in Pediatric Acute Respiratory Distress Syndrome.

Research square·2026
Same author

C6 peptide blockade of Hv1 channels inhibits neutrophil migration into the lungs to suppress Pseudomonas aeruginosa-induced acute lung injury.

Respiratory research·2025
Same author

Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS.

Critical care (London, England)·2025
Same author

Evaluation of a Rapid Immunoassay for Molecular Subphenotype Classification in Pediatric Acute Cardiorespiratory Failure.

Research square·2025
Same author

Outcomes, Characteristics, and Physiology of In-Hospital Cardiac Arrest in Children With Sepsis.

Critical care medicine·2025

Related Experiment Video

Updated: Mar 19, 2026

Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.4K

Biomarkers in Pediatric ARDS: Future Directions.

Benjamin E Orwoll1, Anil Sapru2

  • 1Department of Pediatrics, Division of Critical Care, University of California San Francisco , San Francisco, CA , USA.

Frontiers in Pediatrics
|June 18, 2016
PubMed
Summary

Biomarkers are crucial for understanding pediatric acute respiratory distress syndrome (ARDS). Research is needed to identify specific biological markers for better diagnosis and targeted treatments in children with ARDS.

Keywords:
ARDSPARDSacute lung injurybiomarkerscritical caremolecular phenotypespediatricssurrogate outcomes

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

12.8K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.9K

Related Experiment Videos

Last Updated: Mar 19, 2026

Breath Collection from Children for Disease Biomarker Discovery
06:09

Breath Collection from Children for Disease Biomarker Discovery

Published on: February 14, 2019

7.4K
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

12.8K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.9K

Area of Science:

  • Pediatric critical care medicine
  • Pulmonary medicine
  • Biomarker research

Background:

  • Acute respiratory distress syndrome (ARDS) is a significant cause of mortality in pediatric intensive care units.
  • While biomarkers for ARDS are well-studied in adults, data on pediatric ARDS (pARDS) is limited.
  • Existing ARDS biomarkers offer insights into inflammation, lung injury, and coagulation.

Purpose of the Study:

  • To review the current literature on biomarkers in pediatric ARDS (pARDS).
  • To discuss the potential of biomarkers in identifying high-risk pediatric patients.
  • To explore the role of biomarkers in developing targeted therapies and as surrogate outcomes for pARDS.

Main Methods:

  • Literature review of existing studies on ARDS biomarkers in children.
  • Analysis of data from bronchoalveolar lavage and circulation.
  • Discussion of established and novel biomarkers.

Main Results:

  • Biomarkers have enhanced understanding of ARDS pathobiology in adults, aiding molecular phenotyping.
  • A significant gap exists in the characterization of biomarkers specific to pediatric ARDS.
  • Biomarkers show potential for risk stratification and therapeutic development in pARDS.

Conclusions:

  • Further investigation into biomarkers is essential for characterizing pARDS.
  • Biomarkers may improve risk prediction and guide personalized treatment strategies for children with ARDS.
  • The recent definition of pARDS necessitates further biomarker research to advance clinical care.